KH Group Q2 FY26 operating profit swings to EUR 4.1 million; revenue rises 14.9% to EUR 62.3 million
Reuters2026/08/14 05:00- KH Group posted Q2 revenue of EUR 62.3 million, up 14.9% year over year, as operating profit rose to EUR 4.1 million.
- Q2 net profit swung to EUR 2.4 million; diluted EPS turned positive to EUR 0.03.
- H1 revenue climbed 11.5% to EUR 106.9 million; operating profit rose to EUR 2.7 million, while net loss narrowed to EUR 0.5 million.
- CEO Carl Haglund flagged a strong Q2, citing broad-based profitability gains, with clear improvement in KH-Koneet’s Sweden business.
- Guidance kept unchanged: 2026 revenue and comparable operating profit are expected to grow versus 2025.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
